Genetic Engineering Media

Translation and commercialization of genetically engineered cell therapeutics starts with products that enhance efficiency of modification, as primary cells are traditionally difficult to transduce, requiring higher amounts of viral agents at the detriment of cell robustness and expansion.  With RoosterBio’s genetic engineering solutions, researchers and product developers are emboldened with hyper-efficient, complete media systems to confidently custom-engineer their therapeutic product with simplified processes and complete end-to-end genetically modified MSC platform to streamline the path towards clinical translation.